Abstract:Background. Against the background of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and after multiple vaccinations with various vaccines, the effect of the massive antigenic load that various cohorts of patients received and continue to receive is undeniable. The SARS-CoV-2 epidemic is not over, and the long-term persistence of the virus contributes to the formation of various symptoms, complications, and the surgical emergencies. The symptoms of post-COVID syndrome (PCS) associated with the progression of individual disorders of immune resistance and autoimmune component formation in 40 % of patients is a predictor of the cardiovascular pathology. It is very difficult to provide medical care to patients with a comorbid course of PCS and urgent surgical pathology, and the study of imprinting disorders is important. The aim is to determine the role of impaired immune resistance in patients with comorbid PCS and urgent cardiovascular condition and to identify specific markers associated with the severity of the pathology and high risk of mortality. Materials and methods. We examined 145 patients aged 33 to 84 years who had COVID-19 in different periods of the pandemic with the development of PCS and cardiovascular disease (aortic and femoral artery aneurysm, aortic occlusion, aortic stenosis, thrombosis of major vessels, coronary heart disease, infectious endocarditis, myocardial infarction). Methods used were microscopy (light, luminescent, confocal), spectrophotometry, latex agglutination, immunoturbidimetry, gravimetry, flow cytometry, enzyme-linked immunosorbent assay. Results. We revealed an increase in the frequency of urgent surgical cardiovascular pathologies with the risk of thrombogenic disorders due to immunoinflammatory reactions arising against the background of the formed PCS. In the examined patients with comorbidities, temporal manifestations of individual immunopathological reactions of varying severity were found in different periods of the pandemic. In the first period (2020–2021), against the background of persisters presence, violations of humoral and cellular innate immunity were detected (an increase in C3 and C4 complement components and pro-inflammatory interleukins 6 and 18; phagocytosis dysfunction; presence of antibodies to platelets and nuclear components, including aminoacyl-tRNA synthetase). During this period, the examined patients had a significant increase in the serum content of the oligopeptide cytotoxic DAMP fraction (molecular patterns associated with damage). During the second period (2022–2023), patients with a severe course of comorbidity, especially in cases of mortality (17 %), had an increased oligonucleotide DAMP fraction and an expanded complex of PCS symptoms. This was associated with certain changes in markers of adaptive immunity: the violation in the ratio of T lymphocyte subpopulations against the background of lymphopenia, a significant increase in the level of cytotoxicity inducer — a marker of the early activation of T lymphocytes CD3+CD4+CD25+, a significant decrease in the expression of costimulatory molecules CD3+CD4+CD28+ of T helpers, development of mitochondrial dysfunction and a multiple increase in the antinuclear antibodies. Conclusions. Identified immunological markers of severity and the risk of mortality in patients with a comorbid course of PCS and urgent cardiovascular pathology should be taken into account when developing personalized treatment methods.

Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms

Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic

Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)

High Somatization Rates, Frequent Spontaneous Recovery, and a Lack of Organic Biomarkers in Post‐Covid‐19 Condition

IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)

Prevalence and Risk Factors of Postacute Sequelae of COVID-19 in Adults With Systemic Autoimmune Rheumatic Diseases

Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19

PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females

A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings

High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome

Persistent Autonomic and Immunologic Abnormalities in Neurologic Post-Acute Sequelae of SARS-CoV2 Infection

Definitions and symptoms of the post-COVID syndrome: an updated systematic umbrella review

Latent class analysis of post-acute sequelae of SARS-CoV-2 infection

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection

Peculiarities of impaired immunoresistance in the formation of post-COVID syndrome and the acute cardiovascular pathology

Pathophysiology of Post-COVID syndromes: a new perspective

POST-ACUTE SEQUELAE OF COVID-19: CHARACTERIZATION, COMORBIDITIES, AND BIOMARKERS IN A DIVERSE COHORT